The Atlanta Journal-Constitution

Atlantan among 10 in alleged health fraud

Atlanta man among 10 indicted in alleged $1.4 billion health fraud.

- By Lois Norder lois.norder@ajc.com

Ten people have been charged with bilking insurance companies through a scheme using struggling rural hospitals.

Ten people have been charged with bilking insurance companies through an elaborate scheme using struggling rural hospitals, including the former Chestatee Regional Hospital in Dahlonega, to bill for drug testing.

In an indictment unsealed on Monday, the Department of Justice alleges that the conspirato­rs would obtain urine specimens and other samples for testing through kickbacks paid to recruiters and health care providers, including substance abuse treatment centers. Some of the tests, the government alleges, were not even medically necessary.

The conspirato­rs then billed insurers through the hospitals for about $1.4 billion for lab tests and were paid about $400 million, the government alleges.

In addition to the Georgia hospital, the scheme also involved hospitals in Florida and Missouri, according to the indictment.

Among those charged is Christian Fletcher, 34, of Atlanta, who faces one count of conspiracy to commit health care fraud and wire fraud; one count of conspiracy to commit money laundering; and two counts of substantiv­e money laundering.

The i ndictm e nt identifies Fletcher as the owner of LifeBrite Laboratori­es Inc., a Brookhaven clinical testing lab that performed toxicology testing on urine samples.

In a written statement, Fletcher’s attorney, Steve Sadow of Atlanta, called the accusation­s unjustifie­d and said Fletcher was not guilty of any criminal conduct. “Christian at all times engaged in legitimate, lawful business transactio­ns with third party insurance companies and hospitals,” the statement said in part. Fletcher also so ugh t a nd received legal advice regarding the propriety of his business

practices and dealings, the statement said.

Also indicted is Florida attorney and medical lab president Aaron Durall, 48. Through his company, Durall purchased the 49-bed Chestatee Regional Hospital in 2016, in a plan that was supposed to rescue the struggling facility.

He is charged with one count of conspiracy to commit health care fraud and wire fraud, five counts of substantiv­e health care fraud, two counts of conspiracy to commit money laundering, and three counts of substantiv­e money laundering.

Durall is falsely accused of a crime he did not commit, said his attorney Brian Rafferty of Atlanta in a written statement. Durall, he said, “has cooperated fully in this investigat­ion, testified under oath about it, and is deeply disappoint­ed that the government has ignored the facts...”

The government, Rafferty said, has turned a civil contract dispute with the insurers into a federal criminal case. He added that across the country, the same insurers have had to pay millions of dollars for refusing to pay for the kinds of lab services at issue in the criminal case.

Federal prosecutor­s allege that Durall, Fletcher and two other defendants along with others would research and identify financiall­y distressed small, rural hospitals that they could take over to file claims for lab tests under the hospitals’ in-network contracts with insurers. By billing through the rural hospitals, the government says, reimbursem­ents were significan­tly higher than if the bills were submitted by labs. But the government said none of the rural hospitals had the equipment or laboratory capacity to conduct large-scale urine analysis or blood tests, and that the testing actually took place in independen­t labs.

The lab tests were run for people from throughout the United States who were not patients of the rural hospitals and otherwise had no connection with them, the indictment also alleges.

As the testing bills from the Dahlonega hospital swelled to thousands a month, Blue Cross Blue Shield began to review all lab claims before determinin­g whether to pay them. In response, Durall and another defendant began to submit claims in a manner to conceal the fact that urine analysis tests had been performed, according to the indictment.

In 2018, Blue Cross Blue Shield sued Durall, two of his Florida business associates and Durall’s companies, including the hospital and

Reliance Laboratory Testing, accusing them of using Chestatee to reap millions in improper testing fees. Durall denied any wrongdoing. The lawsuit was resolved with a confidenti­al settlement in 2019, court records show.

The hospital closed about July 2018 and the property was later sold in a transactio­n where University System of Georgia Board of Regents purchased it and then leased it to Northeast Georgia Health System.

Others charged in the federal indictment include hospital managers and owners of laboratori­es and medical billing companies. They are Jorge Perez, 60; Ricardo Perez, 57; Neisha Zaffuto, 44; James Porter Jr., 49; Sean Porter, 52; Aaron Alonzo, 44; and Nestor Rojas, 45, all of Florida, and Seth Guterman, 54, of Chicago.

The case is in federal court in the Middle District of Florida.

Newspapers in English

Newspapers from United States